ϳԹ

Skip to main content

Health + Wellness

$3.8M Grant Investigates Link Between Sleep Apnea and Atrial Fibrillation
CLEVELAND - ϳԹ School of Medicine has received a $3.8 million grant from the National Heart, Lung, and Blood Institute (NHLBI) to study sleep apnea as a possible cause of atrial fibrillation (AF), the most commonly diagnosed type of arrhythmia, or irregular heart rhythm....
Lentingen and UH Case Medical Center Initiate Phase I Trial Using Gene Therapy and Bone Marrow Stem Cells in the Treatment of Brain Cancer
CLEVELAND - University Hospitals (UH) Case Medical Center, ϳԹ School of Medicine and Lentigen Corporation announced today the initiation of a novel Phase I clinical trial of LG631 gene therapy for the protection of hematopoietic stem cells (HSCs) from the dose limiting t...
Helping others helps teens stay on the road to addiction recovery, ϳԹ study says
A new study of teens undergoing substance abuse treatment finds helping others helps the adolescent helper by reducing cravings for alcohol and drugs, a major precipitator of relapse. These novel findings stem from the “Helping Others” study (helpingotherslivesober.org) led by Maria Pagano, PhD, ass...
Society for Integrative Oncology Releases Findings Presented at Annual Meeting
CLEVELAND - Today the Society for Integrative Oncology highlighted top research findings presented at the Eighth International Conference this week in Cleveland, Ohio, which is co-sponsored by ϳԹ School of Medicine. More than 80 abstracts will be presented at the annual ...
Pioneering Professorship Will Teach Innovative, Patient-Centered Approach to Cancer Treatment
CLEVELAND - ϳԹ School of Medicine is honored to announce gifts to establish the inaugural Parker Hannifin – Helen Moss Cancer Research Foundation Professorship in Integrative Oncology. This professorship will establish the School of Medicine and its affiliate hospitals a...
New Therapy Marks a Milestone in Fight against Cystic Fibrosis
CLEVELAND - Results of the pivotal Phase 3 clinical trial published in the Nov. 3, 2011 New England Journal of Medicine, find that the oral medication ivacaftor (VX-770) provides major, sustained improvement in lung function, growth and other signs and symptoms for cystic fibrosis (CF) patients. The...
Mother Nature’s oral antibiotics research gets $2.25 million help from NIH
Research from ϳԹ School of Dental Medicine to study an isolated agent from common oral bacteria may hold the answer as to how human beta defensins (HBDs)—nature’s way of keeping oral microbes from entering the body and wreaking havoc on our health—can be used to create n...
Blame backbone fractures on evolution, not osteoporosis
Osteoporosis is blamed for backbone fractures. The real culprit could well be our own vertebrae, which evolved to absorb the pounding of upright walking, researchers at ϳԹ say. Compared to apes, humans have larger, more porous vertebrae encased in a much thinner shell o...
“Just say ‘Ahhh…’”
CLEVELAND - “Say ‘ahhh.’” That is what ϳԹ student doctors and nurses will be telling patients with sore throats and other health problems Saturday, Oct. 22, during the grand opening of the Student-Run Free Clinic at The Free Medical Clinic of Greater Cleveland, 12201 Euc...
John Chae, MD, Elected to the Institute of Medicine
CLEVELAND - John Chae, MD, has been elected as a new member to the prestigious Institute of Medicine (IOM), one of the highest national honors in the fields of health and medicine. A noted Physical Medicine and Rehabilitation (PM&R) physician specializing in stroke rehabilitation, Dr. Chae has made...